Liraglutide, Insulin Degludec

Liraglutide is a once-daily injectable medication used for the treatment of type 2 diabetes. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps regulate blood sugar levels by stimulating the release of insulin when glucose levels are high and suppressing glucagon secretion when glucose levels are low. This dual action helps to lower blood sugar levels and improve glycemic control.
Liraglutide is typically prescribed as an adjunct to diet and exercise in patients whose blood sugar levels are not adequately controlled by lifestyle changes alone or in combination with other oral diabetes medications. It is also used in combination with other injectable medications, such as insulin, to further improve blood sugar control.
Insulin degludec is a long-acting insulin analogue used for the treatment of diabetes in patients who require basal insulin replacement. It is a once-daily injectable medication that provides a stable and prolonged release of insulin, helping to maintain consistent blood sugar levels throughout the day and night. Insulin degludec is typically used in combination with rapid-acting insulin or other diabetes medications to achieve optimal glycemic control.